Search

everythinglearnresearchcommunity

for

Search:↓

Hair germ cells differ from epidermal cells in keratin expression, and specific keratins form after hair differentiation.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

IL-18 signaling helps mature Tregs move into the thymus.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Ancient immune and signaling pathways still regulate blood cell development.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Hair follicles and sweat glands show different keratin staining patterns.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Restoring hair follicle immune privilege may help treat alopecia areata.

A woman with hypothyroidism developed an allergy to IV levothyroxine after being resistant to oral forms.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

BST2 protein and certain T cells increase in early alopecia areata.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Sex hormones may affect COVID-19 severity and outcomes.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Antibody treatments show promise for hair loss but need more research.